| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.5 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |